Skip to main content
. 2023 Nov 7;31(1):376–381. doi: 10.1245/s10434-023-14439-7

Table 4.

Chemotherapy regimen/cost for HER2 positive patients, neoadjuvant

Taxotere, Carboplatin, Herceptin, and Perjeta (TCHP)
Drug First cycle Second cycle Treatment course
Docetaxel $1428 $1428 $8568 (6 doses)
Carboplatin $368 $368 $2208 (6 doses)
Trastuzumab (Q3 weeks) $19,715 (loading dose) $15,779 (maintenance)

$272,179

(1 loading dose + 16 maintenance doses)

Pertuzumab

(Q3 weeks)

$13,504 (loading dose) $6752 (maintenance)

$121,536

(1 loading dose + 16 maintenance doses)

Total $35,015 $24,327 $404,491